• SENSEX 81,463.09
    -721.08 (--0.88%)
  • BANKNIFTY 56,528.90
    -537.15 (--0.94%)
  • Authum Invest
    2,250.00 985.45(%)
  • Indian Energy Ex
    149.45 244.35(%)
  • Vimta Labs
    598.90 598.90(%)
  • Bharti Airtel
    1,952.40 2,045.50(%)
  • Force Motors
    16,488.00 6,128.55(%)
  • Bajaj Finance
    897.65 642.61(%)
  • Anant Raj
    606.00 947.25(%)
  • Jayaswal Neco
    40.05 26.06(%)
  • Sharda Cropchem
    1,090.25 1,090.25(%)
  • Infosys
    1,511.35 1,307.10(%)
  • Olectra Greentec
    1,460.00 973.65(%)
  • Tata Motors
    685.00 542.55(%)
  • Eternal Ltd
    306.25 189.60(%)
  • Trent
    5,033.80 4,491.75(%)
  • Reliance Industr
    1,384.50 1,115.55(%)
  • Waaree Energies
    3,171.00 1,808.65(%)
  • Phoenix Mills
    1,545.00 1,965.00(%)
  • Kajaria Ceramics
    1,151.00 745.00(%)
  • Adani Green
    972.75 758.00(%)
  • Cipla
    1,553.00 1,702.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Emcure Pharmaceuticals Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 16966.0
  • ISIN : INE168P01015
1,407.80 -18 (-1.23%)
  • As on 26 Jul 2025 (EOD)

  • Today’s Low

    1,405.00

  • Today’s High

    1,433.10

  • Open

    1,425.20

  • Perv Close

    1,425.40

  • 52W Low

    889.00

  • 52W High

    1,580.00

Key Indicators

  • P/E(TTM)

    84.01

  • Mar.Cap (₹Cr.)

    26,678.99

  • Div & Yield %

    0.21

  • Book Value(₹)

    159.59

  • Debt-Equity Ratio

    -1.23

  • AGM Date

    25-Jul-2025

  • EPS

    16.73

  • P/E Ratio

    84.01

Financials Ratios

  • Debt-Equity Ratio

    0.86

  • Mar.Cap (₹Cr.)

    26,678.99

  • RONW (%)

    19.35

  • ROCE (%)

    18.23

Score Board

  • Equity (₹ in Cr.)

    189.51

  • BV (₹)

    159.60

  • Sales( ₹ in Cr.)

    4,381.92

  • NP (in Cr.)

    317.13

  • NP Var(%)

    95.0

  • Div%

    30.0

  • CPS (₹)

    28.60

  • EPS (₹)

    16.70

  • Traded Value (₹ in Lakhs)

    26,636.35

  • 52 Week High

    1,580.00

  • 52 Week Low

    889.00

  • Price BSE

    1406.0

  • Price NSE

    1,408.00

  • Market Capital( in Cr.)

    26,636.35

  • P/C Ratio

    49.20

  • P/E Ratio

    84.00

  • Price Vs.BV

    16.70

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 3,497.66 3,107.09 3,387.24 3,107.41 2,375.71 2,453.70
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 3,497.66 3,107.09 3,387.24 3,107.41 2,375.71 2,453.70
Other Income 138.26 125.35 132.68 96.52 137.62 90.88
Stock Adjustments 101.70 -14.45 36.10 107.96 -59.70 -14.71
Total Income 3,737.62 3,217.99 3,556.02 3,311.89 2,453.63 2,529.87
EXPENDITURE :            
Raw Materials 1,464.67 1,199.25 1,354.99 1,345.85 751.46 730.09
Power and Fuel Cost 88.73 80.41 72.46 73.51 67.29 61.44
Employee Cost 706.41 649.18 603.95 543.92 545.35 516.14
Other Manufacturing Expenses 209.89 192.67 219.39 198.00 127.43 186.81
Selling and Administration Expenses 532.87 443.20 263.11 226.17 342.04 279.22
Miscellaneous Expenses 164.22 95.59 114.78 94.06 103.18 129.84
Employee Benefit Expenses 706.41 649.18 603.95 543.92 545.35 516.14
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 3,166.78 2,660.30 2,628.67 2,481.51 1,936.75 1,903.54
Operating Profit 570.83 557.69 927.36 830.39 516.88 626.33
Interest 166.09 166.83 145.14 118.28 137.22 126.65
Gross Profit 404.74 390.86 782.22 712.11 379.66 499.68
Depreciation 204.83 178.52 165.79 154.21 154.97 129.84
Profit Before Tax 199.91 212.34 616.43 557.90 224.69 369.84
Current Tax 38.58 53.10 168.72 141.65 72.81 91.35
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.50 -0.83 0.89 -4.23 -23.34 -5.17
Reported Net Profit 160.83 160.06 446.81 420.48 175.21 283.65
Extraordinary Items -1.64 -4.80 0.10 -2.90 -32.65 -26.32
Adjusted Net Profit 162.47 164.86 446.71 423.38 207.86 309.97
Adjustment below Net Profit -5.34 4.06 -0.79 0.11 -2.03 0.11
P & L Balance brought forward 1,593.84 1,465.89 1,877.11 1,474.61 1,349.71 989.73
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 54.26 36.17 857.24 18.09 48.27 -76.22
P & L Balance carried down 1,695.08 1,593.84 1,465.89 1,877.11 1,474.61 1,349.71
Dividend 0.00 0.00 36.17 0.00 0.00 45.21
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 20.00 20.00 30.00 10.00 25.00 25.00
Dividend Per Share(Rs) 2.00 2.00 3.00 1.00 2.50 2.50
Earnings Per Share-Unit Curr 8.88 8.85 24.71 23.25 9.69 15.68
Earnings Per Share(Adj)-Unit Curr - - - - - -
Book Value 106.82 101.84 94.69 127.27 105.86 98.29
Book Value(Adj)-Unit Curr - - - - - -

Shareholding Pattern

  • Promoter Group

    77.91%

  • Public Share Holding

    22.09%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 433,932 433,932.00 433,932 433,932
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 433,932 0.23 433,932 2
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 118,187,350 62.37 118,187,350 16
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 29,028,000 15.32 29,028,000 2
Others 0 0.00 0 0
Sub Total 147,215,350 77.68 147,215,350 18
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 5,410,795 2.86 5,410,795 51
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 455,617 0.24 455,617 3
Mutual Funds / UTI 4,431,155 2.34 4,431,155 19
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 499,409 0.26 499,409 11
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 10,796,976 5.70 10,796,976 84
2] Non Institution
Bodies Corporate 1,338,369 0.71 1,338,369 311
Clearing Members 0 0.00 0 0
Directors of their Relatives 343,930 0.18 343,930 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,364,377 0.72 1,364,377 1,100
Foreign Non Institution Other 16,439,459 8.67 16,439,459 1
Hindu Undivided Families 178,664 0.09 178,664 3,259
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 5,957,748 3.14 5,957,748 36
Individuals holding nominal share capital up to Rs. 1 lakh 5,326,632 2.81 5,326,628 128,700
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 1,202 0.00 1,202 3
Others 30,750 0.02 30,750 1
Sub Total 31,062,089 16.39 31,062,085 133,445
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 189,508,347 100.00 189,508,343 133,549

Company Background

Emcure Pharmaceuticals LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Emcure Pharmaceuticals Ltd
  • BSE Code : 16966.0
  • ISIN : INE168P01015

  • Incorporation Year

    1981

  • Registered Office

    Plot # P-1 & P-2 IT BT Park
    Phase II MIDC Hinjawadi, Pune,
    Maharashtra-411057

  • Telephone

    +91 20 3507 0033/+91 20 3507 0000

  • FAX

  • Chairman

    Berjis M Desai

  • Managing Director

    SATISH RAMANLAL MEHTA

  • Company Secretary

    CHETAN RAJENDRA SHARMA

  • Auditor

    B S R & Co LLP

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Emcure Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Emcure Pharma 1,405.55 3,635.91 3,497.66 84.01 10.08
Abbott India 33,771.20 6,684.73 6,409.15 50.74 44.95
Astrazeneca Phar 8,832.65 1,756.92 1,716.29 190.77 32.94
P & G Health Ltd 5,831.90 1,166.89 1,151.26 38.54 39.76
Glaxosmi. Pharma 3,154.75 3,866.05 3,723.49 58.15 58.72
Cipla 1,531.10 20,029.57 19,044.85 23.98 21.40
Amrutanjan Healt 679.00 437.58 421.23 38.62 20.84
Fermenta Biotec. 375.35 442.21 430.53 16.34 17.61
Guj. Themis Bio. 363.35 174.19 169.82 81.10 44.82
Bliss GVS Pharma 153.45 703.42 667.20 23.46 9.16
Ambalal Sarabhai 32.88 19.33 4.04 30.44 2.10